View in EDS HTML Full Text PDF Full Text

The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial.
Authors: Reiersen, Angela M1 (AUTHOR) reiersena@wustl.edu, Mattar, Caline2 (AUTHOR), Ignacio, Rachel A Bender3,4 (AUTHOR), Boulware, David R5 (AUTHOR), Lee, Todd C6,7,8 (AUTHOR), Hess, Rachel9,10 (AUTHOR), Lankowski, Alexander J3 (AUTHOR), McDonald, Emily G7,8,11 (AUTHOR), Miller, J Philip12 (AUTHOR), Powderly, William G2 (AUTHOR), Pullen, Matthew F5 (AUTHOR), Rado, Jeffrey T13 (AUTHOR), Rich, Michael W14 (AUTHOR), Schiffer, Joshua T3,4 (AUTHOR), Schweiger, Julie1 (AUTHOR), Spivak, Adam M15 (AUTHOR), Stevens, Angela1 (AUTHOR), Vigod, Simone N16 (AUTHOR), Agarwal, Payal17 (AUTHOR), Yang, Lei1 (AUTHOR)
Source: Open Forum Infectious Diseases. Aug2023, Vol. 10 Issue 8, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofad419